R M Gangemi
Overview
Explore the profile of R M Gangemi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heins N, Cremisi F, Malatesta P, Gangemi R, Corte G, Price J, et al.
Mol Cell Neurosci
. 2002 Apr;
18(5):485-502.
PMID: 11922140
Distinct sets of precursor cells generate the mammalian cerebral cortex. During neurogenesis most precursors are specified to generate a single cell type and only few are multipotent. The cell-intrinsic molecular...
2.
Gangemi R, Daga A, Marubbi D, Rosatto N, Capra M, Corte G
Mech Dev
. 2001 Dec;
109(2):323-9.
PMID: 11731244
Emx2 is a vertebrate homeobox gene involved in the control of the central nervous system development. In the formation of cerebral cortex, Emx2 expression is restricted mainly to the germinal...
3.
Gangemi R, Santamaria B, Bargellesi A, Cosulich E, Fabbi M
Int J Cancer
. 2000 Mar;
85(4):527-33.
PMID: 10699926
The efficacy of taxanes on human leukemia cells is the object of intensive in vitro investigation concerning the influence of cell-type-specific characteristics on cytotoxic response to drugs. The present study...
4.
Gangemi R, Costa G, Fulco R, DAquino S, Aronadio O
Ann N Y Acad Sci
. 1996 Apr;
784:550-4.
PMID: 8651615
No abstract available.
5.
Gangemi R, Tiso M, Marchetti C, Severi A, Fabbi M
Cancer Chemother Pharmacol
. 1995 Jan;
36(5):385-92.
PMID: 7634380
Taxol is the prototype of a class of antineoplastic drugs that target microtubules. It enhances tubulin-monomer polymerization and stabilizes tubulin polymers, increasing the fraction of cells in the G2 or...
6.
Fabbi M, Tiso M, Gangemi R, Favre A, DeMartini P
Eur J Immunol
. 1994 Jan;
24(1):1-7.
PMID: 8020545
In this study we report the characterization of monoclonal antibody (mAb) 8B4/20, raised against immature human thymocytes, that identifies a novel leukocyte antigen. The molecular characterization of the antigen by...
7.
Singh A, Gangemi R, Barrett K
Autoimmunity
. 1994 Jan;
18(1):65-75.
PMID: 7999957
To investigate the structural contribution of the light chain of anti-DNA antibodies to fine specificity, the VKappa genes of two monoclonal anti-DNA antibodies, termed H241 and H102, were cloned and...
8.
Gangemi R, Singh A, Barrett K
J Immunol
. 1993 Nov;
151(9):4660-71.
PMID: 8409427
The origin and structure of two clonally unrelated IgG anti-DNA autoantibodies from lupus-prone MRL/Ipr mice were examined. One of these antibodies, H241, binds dsDNA and glomeruli and deposits in the...
9.
Swack J, Gangemi R, Rudd C, Morimoto C, Schlossman S, Romain P
Mol Immunol
. 1989 Nov;
26(11):1037-49.
PMID: 2481822
Studies from our laboratory have shown that anti-T12, a mAb which recognizes CD6, is a macrophage-dependent mitogen for human T cells and can augment T cell autoreactivity in vitro. To...
10.
Gangemi R, Swack J, Gaviria D, Romain P
J Immunol
. 1989 Oct;
143(8):2439-47.
PMID: 2794503
Anti-T12 is a murine IgM mAb that recognizes the 130-kDa CD6 glycoprotein on mature human T lymphocytes. Examination of the in vitro effects of this mAb on freshly isolated T...